Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis

被引:0
作者
Yuko Kanbayashi
Yuichi Ishizuka
Mayumi Shimizu
Shohei Sawa
Katsushige Yabe
Mayako Uchida
机构
[1] Osaka Medical and Pharmaceutical University,Department of Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy
[2] Seirei Hamamatsu General Hospital,Department of Pharmacy
[3] Doshisha Women’s College of Liberal Arts,Department of Education and Research Center for Pharmacy Practice
来源
Supportive Care in Cancer | 2022年 / 30卷
关键词
OIC; Laxatives; Taxane; Naldemedine; BMI; Cancer pain;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5831 / 5836
页数:5
相关论文
共 126 条
[1]  
Mercadante S(2011)Emerging drugs for cancer-related pain Support Care Cancer 19 1887-1893
[2]  
Wiffen PJ(2017)Opioids for cancer pain - an overview of Cochrane reviews Cochrane Database Syst Rev 7 CD012592-1033
[3]  
Wee B(2015)Opioid risk assessment in palliative medicine Expert Opin Drug Saf 14 1023-110
[4]  
Derry S(2021)Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients BMC Palliat Care 20 1-35
[5]  
Bell RF(2019)Opioid-induced constipation in oncological patients: new strategies of management Curr Treat Options Oncol 20 91-20
[6]  
Moore RA(2021)Opioid-induced constipation in advanced cancer patients Cureus 13 e14386-722
[7]  
Krashin D(2021)Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer Int J Clin Oncol 26 104-33
[8]  
Murinova N(2016)Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment Expert Rev Qual Life Cancer Care 1 25-225
[9]  
Jumelle P(2019)Pathophysiology and management of opioid-induced constipation: European expert consensus statement United European Gastroenterol J 7 7-183
[10]  
Ballantyne J(2020)Opioid-induced constipation: a review of health-related quality of life, patient burden, practical clinical considerations, and the impact of peripherally acting μ-opioid receptor antagonists Clin J Pain 36 716-1273.e3